Literature DB >> 6820016

Radiation therapy in the prevention of heterotopic ossification after total hip arthroplasty.

J R Parkinson, C M Evarts, L F Hubbard.   

Abstract

The administration of radiation to prevent heterotopic bone formation after total hip arthroplasty has been highly successful in this prospective study. It was extremely effective in high-risk patients, including those with preexisting heterotopic ossification. No early deleterious effects were noted. Long-term follow-up is planned to observe for late tumor induction. No wound complications were encountered. Trochanteric nonunions did occur and may be in part related to the radiation. This study demonstrated the importance of the early initiation of treatment. Ninety-eight percent of high-risk patients who began treatment on the second to fourth day postoperatively were free of heterotopic bone after surgery. Meticulous technique is always employed to eliminate debris in the surgical wound, and soft tissues are handled carefully. The search continues for a more complete explanation of the pathogenesis of heterotopic bone formation. A current study has been constructed to demonstrate the minimum dose of radiation that will continue to be effective. Further evaluation of methods to more accurately identify the high-risk patient continues. The effectiveness of radiation therapy in the prevention of heterotopic bone following total hip replacement has been shown.

Entities:  

Mesh:

Year:  1982        PMID: 6820016

Source DB:  PubMed          Journal:  Hip        ISSN: 0095-7216


  9 in total

1.  The radiosensitivity of satellite cells: cell cycle regulation, apoptosis and oxidative stress.

Authors:  Vincent J Caiozzo; Erich Giedzinski; Mike Baker; Tatiana Suarez; Atefeh Izadi; Mary Lan; Jennie Cho-Lim; Bertrand P Tseng; Charles L Limoli
Journal:  Radiat Res       Date:  2010-08-02       Impact factor: 2.841

2.  Satellite cells say NO to radiation.

Authors:  Jennie J Cho-Lim; Vincent J Caiozzo; Bertrand P Tseng; Erich Giedzinski; Mike J Baker; Charles L Limoli
Journal:  Radiat Res       Date:  2011-02-14       Impact factor: 2.841

3.  Heterotopic bone formation about the hip undergoes endochondral ossification: a rabbit model.

Authors:  Oliver Tannous; Alec C Stall; Cullen Griffith; Christopher T Donaldson; Rudolph J Castellani; Vincent D Pellegrini
Journal:  Clin Orthop Relat Res       Date:  2013-01-30       Impact factor: 4.176

4.  Nanogel-Mediated RNAi Against Runx2 and Osx Inhibits Osteogenic Differentiation in Constitutively Active BMPR1A Osteoblasts.

Authors:  Arun R Shrivats; Michael C McDermott; Molly Klimak; Saadyah E Averick; Haichun Pan; Krzysztof Matyjaszewski; Yuji Mishina; Jeffrey O Hollinger
Journal:  ACS Biomater Sci Eng       Date:  2015-09-25

5.  [Effect of a calcium inhibitor, verapamil, on the development of heterotopic ossifications. An experimental study in rats].

Authors:  J Duriez; B Flautre; M C Blary; R Duriez
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

6.  Prevention of heterotopic ossification in hip arthroplasties by means of an early single-dose radiotherapy (6 Gy).

Authors:  P Schai; R Brunner; E Morscher; K H Schubert
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

7.  Is preoperative radiation therapy as effective as postoperative radiation therapy for heterotopic ossification prevention in acetabular fractures?

Authors:  Michael T Archdeacon; Albert d'Heurle; Nicole Nemeth; Bradley Budde
Journal:  Clin Orthop Relat Res       Date:  2014-06-04       Impact factor: 4.176

Review 8.  [Neurogenic osteoarthritis in Guillain Barre syndrome: a rare complication (case report and review of the literature)].

Authors:  Hatim Abid; Mohamed El Idrissi; Mohamed Shimi; Abdelhalim El Ibrahimi; Abdelmajid El Mrini
Journal:  Pan Afr Med J       Date:  2015-03-13

9.  Validation of a Radiography-Based Quantification Designed to Longitudinally Monitor Soft Tissue Calcification in Skeletal Muscle.

Authors:  Stephanie N Moore; Gregory D Hawley; Emily N Smith; Nicholas A Mignemi; Rivka C Ihejirika; Masato Yuasa; Justin M M Cates; Xulei Liu; Jonathan G Schoenecker
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.